Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Poly(Sarcosine) Surface Modification Imparts Stealth-Like Properties to Liposomes.

Bleher S, Buck J, Muhl C, Sieber S, Barnert S, Witzigmann D, Huwyler J, Barz M, Süss R.

Small. 2019 Dec;15(50):e1904716. doi: 10.1002/smll.201904716. Epub 2019 Nov 13.

PMID:
31722126
2.

The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.

Kolter M, Wittmann M, Köll-Weber M, Süss R.

Eur J Pharm Biopharm. 2019 Jul;140:20-28. doi: 10.1016/j.ejpb.2019.04.013. Epub 2019 Apr 20.

PMID:
31015019
3.

Diabetes Prevention and Care Programs in the US-Affiliated Pacific Islands: Challenges, Innovation, and Recommendations for Effective Scale-Up.

Hawley NL, Suss R, Cash HL, Aitaoto N, Samoa R, Ayers B, McElfish P.

Curr Diab Rep. 2019 Mar 27;19(5):24. doi: 10.1007/s11892-019-1139-0. Review.

PMID:
30919169
4.
5.

pH-Dependent Membrane Interactions of the Histidine-Rich Cell-Penetrating Peptide LAH4-L1.

Wolf J, Aisenbrey C, Harmouche N, Raya J, Bertani P, Voievoda N, Süss R, Bechinger B.

Biophys J. 2017 Sep 19;113(6):1290-1300. doi: 10.1016/j.bpj.2017.06.053. Epub 2017 Jul 19.

6.

Combined Use of MALDI-TOF Mass Spectrometry and 31P NMR Spectroscopy for Analysis of Phospholipids.

Schröter J, Popkova Y, Süß R, Schiller J.

Methods Mol Biol. 2017;1609:107-122. doi: 10.1007/978-1-4939-6996-8_11.

PMID:
28660578
7.

Polysarcosine-Based Lipids: From Lipopolypeptoid Micelles to Stealth-Like Lipids in Langmuir Blodgett Monolayers.

Weber B, Seidl C, Schwiertz D, Scherer M, Bleher S, Süss R, Barz M.

Polymers (Basel). 2016 Dec 9;8(12). pii: E427. doi: 10.3390/polym8120427.

8.

RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy.

Rengaswamy V, Zimmer D, Süss R, Rössler J.

J Control Release. 2016 Aug 10;235:319-327. doi: 10.1016/j.jconrel.2016.05.063. Epub 2016 Jun 1.

PMID:
27261335
9.

Monitoring the pH Triggered Collapse of Liposomes in the Far IR Hydrogen Bonding Continuum.

Srour B, Erhard B, Süss R, Hellwig P.

J Phys Chem B. 2016 May 5;120(17):4047-52. doi: 10.1021/acs.jpcb.6b03759. Epub 2016 Apr 26.

PMID:
27092567
10.

IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma.

Beuschlein F, Jakoby J, Mentz S, Zambetti G, Jung S, Reincke M, Süss R, Hantel C.

Mol Cell Endocrinol. 2016 Jun 15;428:82-8. doi: 10.1016/j.mce.2016.03.023. Epub 2016 Mar 17.

PMID:
26994514
11.

MALDI-TOF MS to monitor the kinetics of phospholipase A2-digestion of oxidized phospholipids.

Schröter J, Süß R, Schiller J.

Methods. 2016 Jul 15;104:41-7. doi: 10.1016/j.ymeth.2015.12.013. Epub 2015 Dec 22.

PMID:
26721598
12.

Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects.

Jakoby J, Beuschlein F, Mentz S, Hantel C, Süss R.

Oncotarget. 2015 Dec 22;6(41):43698-711. doi: 10.18632/oncotarget.6191.

13.

A first step toward liposome-mediated intracellular bacteriophage therapy.

Nieth A, Verseux C, Barnert S, Süss R, Römer W.

Expert Opin Drug Deliv. 2015;12(9):1411-24. doi: 10.1517/17425247.2015.1043125. Epub 2015 May 2.

PMID:
25937143
14.

Intracellular plasma membrane guidance of Photorhabdus asymbiotica toxin is crucial for cell toxicity.

Jank T, Trillhaase C, Brozda N, Steinemann M, Schwan C, Süss R, Aktories K.

FASEB J. 2015 Jul;29(7):2789-802. doi: 10.1096/fj.14-269381. Epub 2015 Mar 17.

PMID:
25782990
15.

CT angiography of the cerebral venous system: anatomic structure, pathologic features, and pitfalls: resident and fellow education feature.

Pond JB, Suss RA, Scott HD, Chason DP.

Radiographics. 2015 Mar-Apr;35(2):498-9. doi: 10.1148/rg.352140129. No abstract available.

PMID:
25763732
16.

Short-chain glycoceramides promote intracellular mitoxantrone delivery from novel nanoliposomes into breast cancer cells.

Pedrosa LR, Ten Hagen TL, Süss R, van Hell A, Eggermont AM, Verheij M, Koning GA.

Pharm Res. 2015 Apr;32(4):1354-67. doi: 10.1007/s11095-014-1539-4. Epub 2014 Oct 16.

PMID:
25319103
17.

Evaluation of a commercial enzymatic test kit regarding the quantitative analysis of different free fatty acids.

Eibisch M, Popkova Y, Süß R, Schiller J, Dannenberger D.

Anal Bioanal Chem. 2014 Nov;406(28):7401-5. doi: 10.1007/s00216-014-8162-4. Epub 2014 Sep 17.

PMID:
25228077
18.

Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy.

Schaffran T, Jiang N, Bergmann M, Küstermann E, Süss R, Schubert R, Wagner FM, Awad D, Gabel D.

Int J Nanomedicine. 2014 Jul 29;9:3583-90. doi: 10.2147/IJN.S65166. eCollection 2014.

19.

The hero with a thousand faces visits the doctor.

Suss R.

Can Fam Physician. 2014 Jul;60(7):656. No abstract available.

20.

Efficient human breast cancer xenograft regression after a single treatment with a novel liposomal formulation of epirubicin prepared using the EDTA ion gradient method.

Gubernator J, Lipka D, Korycińska M, Kempińska K, Milczarek M, Wietrzyk J, Hrynyk R, Barnert S, Süss R, Kozubek A.

PLoS One. 2014 Mar 12;9(3):e91487. doi: 10.1371/journal.pone.0091487. eCollection 2014.

21.

Stationary phase thickness determines the quality of thin-layer chromatography/matrix-assisted laser desorption and ionization mass spectra of lipids.

Griesinger H, Fuchs B, Süß R, Matheis K, Schulz M, Schiller J.

Anal Biochem. 2014 Apr 15;451:45-7. doi: 10.1016/j.ab.2014.02.002. Epub 2014 Feb 11.

PMID:
24530848
22.

Vitamin C-driven epirubicin loading into liposomes.

Lipka D, Gubernator J, Filipczak N, Barnert S, Süss R, Legut M, Kozubek A.

Int J Nanomedicine. 2013;8:3573-85. doi: 10.2147/IJN.S47745. Epub 2013 Sep 23.

23.

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906).

Scherzinger-Laude K, Schönherr C, Lewrick F, Süss R, Francese G, Rössler J.

Int J Nanomedicine. 2013;8:2197-211. doi: 10.2147/IJN.S44025. Epub 2013 Jun 20.

24.

A simple method to identify ether lipids in spermatozoa samples by MALDI-TOF mass spectrometry.

Nimptsch A, Fuchs B, Süß R, Zschörnig K, Jakop U, Göritz F, Schiller J, Müller K.

Anal Bioanal Chem. 2013 Aug;405(21):6675-82. doi: 10.1007/s00216-013-7147-z. Epub 2013 Jun 30.

PMID:
23812881
25.

Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain sphingolipids.

Pedrosa LR, van Hell A, Süss R, van Blitterswijk WJ, Seynhaeve AL, van Cappellen WA, Eggermont AM, ten Hagen TL, Verheij M, Koning GA.

Pharm Res. 2013 Jul;30(7):1883-95. doi: 10.1007/s11095-013-1031-6. Epub 2013 May 11.

PMID:
23666266
26.

Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.

Li L, ten Hagen TL, Hossann M, Süss R, van Rhoon GC, Eggermont AM, Haemmerich D, Koning GA.

J Control Release. 2013 Jun 10;168(2):142-50. doi: 10.1016/j.jconrel.2013.03.011. Epub 2013 Mar 21.

PMID:
23524188
27.
28.

Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma.

Hantel C, Lewrick F, Reincke M, Süss R, Beuschlein F.

J Endocrinol. 2012 May;213(2):155-61. doi: 10.1530/JOE-11-0427. Epub 2012 Mar 9.

PMID:
22407999
29.

Treatment of experimental brain metastasis with MTO-liposomes: impact of fluidity and LRP-targeting on the therapeutic result.

Orthmann A, Zeisig R, Süss R, Lorenz D, Lemm M, Fichtner I.

Pharm Res. 2012 Jul;29(7):1949-59. doi: 10.1007/s11095-012-0723-7. Epub 2012 Mar 8.

PMID:
22399388
30.

Fusogenic activity of PEGylated pH-sensitive liposomes.

Vanić Z, Barnert S, Süss R, Schubert R.

J Liposome Res. 2012 Jun;22(2):148-57. doi: 10.3109/08982104.2011.633267. Epub 2011 Dec 10.

PMID:
22149717
31.

Phosphatidylcholine dimers can be easily misinterpreted as cardiolipins in complex lipid mixtures: a matrix-assisted laser desorption/ionization time-of-flight mass spectrometric study of lipids from hepatocytes.

Eibisch M, Zellmer S, Gebhardt R, Süss R, Fuchs B, Schiller J.

Rapid Commun Mass Spectrom. 2011 Sep 30;25(18):2619-26. doi: 10.1002/rcm.5161.

PMID:
23657956
32.

Watching death.

Suss R.

Can Fam Physician. 2011 Apr;57(4):457. No abstract available.

33.

Targeted delivery to neuroblastoma of novel siRNA-anti-GD2-liposomes prepared by dual asymmetric centrifugation and sterol-based post-insertion method.

Adrian JE, Wolf A, Steinbach A, Rössler J, Süss R.

Pharm Res. 2011 Sep;28(9):2261-72. doi: 10.1007/s11095-011-0457-y. Epub 2011 May 19.

PMID:
21594716
34.

Lipid analysis by thin-layer chromatography--a review of the current state.

Fuchs B, Süss R, Teuber K, Eibisch M, Schiller J.

J Chromatogr A. 2011 May 13;1218(19):2754-74. doi: 10.1016/j.chroma.2010.11.066. Epub 2010 Dec 3. Review.

PMID:
21167493
35.

An update of MALDI-TOF mass spectrometry in lipid research.

Fuchs B, Süss R, Schiller J.

Prog Lipid Res. 2011 Jan;50(1):132. doi: 10.1016/j.plipres.2010.10.001. Epub 2010 Oct 16. No abstract available.

PMID:
20937305
36.

How will you need me, how will you read me, when I'm 64 (or more!)?: volume computed tomographic scanning and information overload in the emergency department.

Chason DP, Anderson JA, Stephens JS, Suss RA, Guild JB, Blackburn TJ, Champine JG, Lane TJ.

Curr Probl Diagn Radiol. 2010 Sep-Oct;39(5):212-26. doi: 10.1067/j.cpradiol.2009.07.007.

PMID:
20674768
37.

An update of MALDI-TOF mass spectrometry in lipid research.

Fuchs B, Süss R, Schiller J.

Prog Lipid Res. 2010 Oct;49(4):450-75. doi: 10.1016/j.plipres.2010.07.001. Epub 2010 Jul 17. Review.

PMID:
20643161
38.

The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.

Gubernator J, Chwastek G, Korycińska M, Stasiuk M, Grynkiewicz G, Lewrick F, Süss R, Kozubek A.

J Control Release. 2010 Aug 17;146(1):68-75. doi: 10.1016/j.jconrel.2010.05.021. Epub 2010 May 24.

PMID:
20510316
39.

Differently complex oligosaccharides can be easily identified by matrix-assisted laser desorption and ionization time-of-flight mass spectrometry directly from a standard thin-layer chromatography plate.

Nimptsch K, Süss R, Riemer T, Nimptsch A, Schnabelrauch M, Schiller J.

J Chromatogr A. 2010 Jun 4;1217(23):3711-5. doi: 10.1016/j.chroma.2010.04.005. Epub 2010 Apr 13.

PMID:
20434160
40.

Intracellular FRET analysis of lipid/DNA complexes using flow cytometry and fluorescence imaging techniques.

Schneider S, Lenz D, Holzer M, Palme K, Süss R.

J Control Release. 2010 Aug 3;145(3):289-96. doi: 10.1016/j.jconrel.2010.04.016. Epub 2010 Apr 22.

PMID:
20417238
41.

Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.

Adrian JE, Morselt HW, Süss R, Barnert S, Kok JW, Asgeirsdóttir SA, Ruiters MH, Molema G, Kamps JA.

J Control Release. 2010 Jun 15;144(3):341-9. doi: 10.1016/j.jconrel.2010.03.003. Epub 2010 Mar 11.

PMID:
20226822
42.

Remote loading of anthracyclines into liposomes.

Lewrick F, Süss R.

Methods Mol Biol. 2010;605:139-45. doi: 10.1007/978-1-60327-360-2_9.

PMID:
20072878
43.

Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).

Huber K, Schemies J, Uciechowska U, Wagner JM, Rumpf T, Lewrick F, Süss R, Sippl W, Jung M, Bracher F.

J Med Chem. 2010 Feb 11;53(3):1383-6. doi: 10.1021/jm901055u.

PMID:
20030343
44.

Spectral bio-imaging and confocal imaging of the intracellular distribution of lipoplexes.

Schneider S, Süss R.

Methods Mol Biol. 2010;606:457-67. doi: 10.1007/978-1-60761-447-0_31.

PMID:
20013415
45.

Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiency.

Hantel C, Lewrick F, Schneider S, Zwermann O, Perren A, Reincke M, Süss R, Beuschlein F.

J Clin Endocrinol Metab. 2010 Feb;95(2):943-52. doi: 10.1210/jc.2009-1980. Epub 2009 Dec 1.

PMID:
19952224
46.
47.

The intact muscle lipid composition of bulls: an investigation by MALDI-TOF MS and 31P NMR.

Dannenberger D, Süss R, Teuber K, Fuchs B, Nuernberg K, Schiller J.

Chem Phys Lipids. 2010 Feb;163(2):157-64. doi: 10.1016/j.chemphyslip.2009.10.011. Epub 2009 Nov 10.

PMID:
19900429
48.

Capabilities and drawbacks of phospholipid analysis by MALDI-TOF mass spectrometry.

Fuchs B, Nimptsch A, Süss R, Schiller J.

Methods Mol Biol. 2009;579:103-25. doi: 10.1007/978-1-60761-322-0_6.

PMID:
19763473
49.

Phosphatidylcholines and -ethanolamines can be easily mistaken in phospholipid mixtures: a negative ion MALDI-TOF MS study with 9-aminoacridine as matrix and egg yolk as selected example.

Fuchs B, Bischoff A, Süss R, Teuber K, Schürenberg M, Suckau D, Schiller J.

Anal Bioanal Chem. 2009 Dec;395(8):2479-87. doi: 10.1007/s00216-009-3032-1.

PMID:
19690837
50.

Do Lego guns cause crime?: A light-hearted review of case-control, cohort, and RCT study designs.

Suss R.

Can Fam Physician. 2008 Nov;54(11):1635-6. Review. No abstract available.

Supplemental Content

Support Center